In a world beset by serious and unconscionable health disparities, by dangerous contagions that can circle our globalized planet in hours, and by a bewildering confusion of health actors and systems, humankind needs a new vision, a new architecture, new coordination among renewed systems to ensure central health capabilities for all. In her new book, “Global Health Justice and Governance,” Dr. Prah Ruger lays out the critical problems facing the world today and offers a new theory of justice and governance as a way to resolve these seemingly intractable issues. Read More
Join us on Friday for Health Policy Biothics Consortium!
Black-box medicine—the use of opaque computational models to make care decisions—has the potential to shape health care by improving and aiding many medical tasks. For example, IBM Watson for Oncology is a machine-learning system that intends to help clinicians quickly identify essential information in patients’ medical records and explore treatment options for 13 cancers. However, it has only recently emerged that the recommendations Watson for Oncology gave for cancer treatments were “often incorrect” and that IBM kept this defect secret for over a year. What are the ethical and legal issues of black-box medicine? When do algorithms operate like a “black box“? How can we ensure that artificial intelligence technologies deliver what they promise? Read More
Despite leaps in biomedical innovation in the developed world, inequalities in global health outcomes persist, as well as systemic barriers to public health and health services. However, the struggle for health rights and global health justice continues.
The Petrie-Flom Center for Health Law Policy is therefore thrilled to announce the launch of the Global Health and Rights Project (GHRP), which will promote theorization of a “right to health” under international law as well as applicable domestic law, challenges to using human rights frameworks to advance global health justice, the relationship between global economic and health governance, and more. Read More
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive, and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
We are excited, therefore, to have many major thought leaders in this space discuss these issues at the Petrie-Flom Annual Conference, “Consuming Genetics: Ethical and Legal Considerations of New Technologies,” which will take place at Harvard Law School in May. Read More
Loyola University Chicago School of Law and the American Society of Law, Medicine & Ethics look forward to hosting the 42nd Annual Health Law Professors Conference on June 5-7, 2019 in Chicago.
We welcome your proposals for the conference program, which should be submitted via this form by January 15, 2019.
We are also pleased to introduce a new opportunity to publish your work in a special post-conference issue of the Journal of Law, Medicine & Ethics. Further details are provided below the fold.
The DePaul Journal of Health Care Law is a student-run peer-reviewed journal published by the DePaul University College of Law. Founded in 1996, the JHCL publishes articles analyzing the legal complexities of the rapidly evolving health care world on topics of interest to health care practitioners, legal researchers, scholars and health care professionals. The editors welcome submission of manuscripts on health law topics, as well as on topics in the broader field of health care where matters of ethics, medical practice or economics have legal implications.
As a scholar working in health law and bioethics, a persistent concern of mine has been the somewhat limited connections between those fields and scholars in the social sciences, particularly political science, economics, and sociology.
Perhaps the best venue for interchange among the social sciences and law may be less well known among folks in health law and bioethics than it should be (at least to judge from inquiries I received when I posted a recent call for papers on the mcw bioethics listserv): the Law and Society Association (LSA).
Please join us for a conversation with John Carreyrou, Investigative reporter for the Wall Street Journal and author of the New York Times bestseller “Bad Blood: Secrets and Lies in a Silicon Valley Startup.”
Carreyrou will discuss his book about the rise and fall of Silicon Valley darling, the blood testing company Theranos, and its charismatic, Stanford drop-out CEO, Elizabeth Holmes.
In recent weeks, news has emerged that the company will in fact cease operations, despite a short-lived attempt to survive after removing Holmes.
The American Society for Law, Medicine & Ethics (ASLME) is pleased to announce the 4th annual bioIP Faculty Workshop on Friday April 26, 2019, at Boston University.
The Workshop offers a unique opportunity for three scholars in their first decade of teaching to present their work in progress for in-depth critique and commentary by respected senior scholars in the field.
We are so excited to welcome a new crop of Student Fellows to the Petrie-Flom Center family. These six students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from Harvard Law School, the Harvard T.H. Chan School of Public Health, Harvard Medical School, and the HMS Center for Bioethics.
They will each undertake a year-long research project with mentorship from Center faculty and affiliates, and will also regularly be blogging here at Bill of Health. Keep an eye out for their bylines!